{"entity":{"type":"insider","cik":"0001758507","url":"/insider/0001758507","json_url":"/insider/0001758507.json","name":"NOUGUES MAXIMO F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":34,"first":"2021-01-06","last":"2026-07-08","span_basis":"filed_date"},"name_variants":[{"name":"NOUGUES MAXIMO F","source":"filing","n_filings":34,"first_seen":"2021-01-06","last_seen":"2026-07-08"}],"transactions":[{"id":6166273,"accession":"0001437749-26-023077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-023077","line_url":"/filing/0001437749-26-023077#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9386.0,"shares_display":"9,386","price_per_share":8.263,"price_display":"8.26","price_state":"stated","total_value":77556.518,"total_display":"77,556.52","total_whole":"77,557","shares_owned_after":230637.0,"shares_owned_after_display":"230,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":6037587,"accession":"0001437749-26-000921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-000921","line_url":"/filing/0001437749-26-000921#line-2","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6405.0,"shares_display":"6,405","price_per_share":5.879,"price_display":"5.88","price_state":"stated","total_value":37654.995,"total_display":"37,655.00","total_whole":"37,655","shares_owned_after":193284.0,"shares_owned_after_display":"193,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider"},{"id":6037583,"accession":"0001437749-26-000921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-000921","line_url":"/filing/0001437749-26-000921#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4540.0,"shares_display":"4,540","price_per_share":5.844,"price_display":"5.84","price_state":"stated","total_value":26531.76,"total_display":"26,531.76","total_whole":"26,532","shares_owned_after":199689.0,"shares_owned_after_display":"199,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4863630,"accession":"0001437749-25-022551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-25-022551","line_url":"/filing/0001437749-25-022551#line-2","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3935.0,"shares_display":"3,935","price_per_share":3.535,"price_display":"3.54","price_state":"stated","total_value":13910.225,"total_display":"13,910.22","total_whole":"13,910","shares_owned_after":204229.0,"shares_owned_after_display":"204,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-10","scope":"insider"},{"id":4863628,"accession":"0001437749-25-022551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-022551","line_url":"/filing/0001437749-25-022551#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5587.0,"shares_display":"5,587","price_per_share":3.533,"price_display":"3.53","price_state":"stated","total_value":19738.871,"total_display":"19,738.87","total_whole":"19,739","shares_owned_after":208164.0,"shares_owned_after_display":"208,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-08","filed_date":"2025-07-10","scope":"insider"},{"id":4110317,"accession":"0001437749-25-000365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-000365","line_url":"/filing/0001437749-25-000365#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10227.0,"shares_display":"10,227","price_per_share":3.1517,"price_display":"3.15","price_state":"stated","total_value":32232.4359,"total_display":"32,232.44","total_whole":"32,232","shares_owned_after":152295.0,"shares_owned_after_display":"152,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-03","scope":"insider"},{"id":2393780,"accession":"0001437749-24-023022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-023022","line_url":"/filing/0001437749-24-023022#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4156.0,"shares_display":"4,156","price_per_share":3.7011,"price_display":"3.70","price_state":"stated","total_value":15381.7716,"total_display":"15,381.77","total_whole":"15,382","shares_owned_after":162522.0,"shares_owned_after_display":"162,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-18","scope":"insider"},{"id":2224253,"accession":"0001437749-24-022067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-022067","line_url":"/filing/0001437749-24-022067#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5295.0,"shares_display":"5,295","price_per_share":3.2685,"price_display":"3.27","price_state":"stated","total_value":17306.7075,"total_display":"17,306.71","total_whole":"17,307","shares_owned_after":166678.0,"shares_owned_after_display":"166,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-02","scope":"insider"},{"id":3238563,"accession":"0001437749-24-000768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-000768","line_url":"/filing/0001437749-24-000768#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15682.0,"shares_display":"15,682","price_per_share":4.4859,"price_display":"4.49","price_state":"stated","total_value":70347.8838,"total_display":"70,347.88","total_whole":"70,348","shares_owned_after":128666.0,"shares_owned_after_display":"128,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8495738,"accession":"0001437749-23-019525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-019525","line_url":"/filing/0001437749-23-019525#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14680.0,"shares_display":"14,680","price_per_share":3.3112,"price_display":"3.31","price_state":"stated","total_value":48608.416,"total_display":"48,608.42","total_whole":"48,608","shares_owned_after":144348.0,"shares_owned_after_display":"144,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8562426,"accession":"0001437749-23-000547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-000547","line_url":"/filing/0001437749-23-000547#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10499.0,"shares_display":"10,499","price_per_share":4.1779,"price_display":"4.18","price_state":"stated","total_value":43863.7721,"total_display":"43,863.77","total_whole":"43,864","shares_owned_after":100427.0,"shares_owned_after_display":"100,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6543875,"accession":"0001437749-22-028558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-028558","line_url":"/filing/0001437749-22-028558#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159.0,"shares_display":"159","price_per_share":4.4978,"price_display":"4.50","price_state":"stated","total_value":715.1502,"total_display":"715.15","total_whole":"715","shares_owned_after":110926.0,"shares_owned_after_display":"110,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6273844,"accession":"0001437749-22-026032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-026032","line_url":"/filing/0001437749-22-026032#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163.0,"shares_display":"163","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":366.75,"total_display":"366.75","total_whole":"367","shares_owned_after":111085.0,"shares_owned_after_display":"111,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-04","scope":"insider"},{"id":6449936,"accession":"0001437749-22-023679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-023679","line_url":"/filing/0001437749-22-023679#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":2.3354,"price_display":"2.34","price_state":"stated","total_value":385.341,"total_display":"385.34","total_whole":"385","shares_owned_after":111248.0,"shares_owned_after_display":"111,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6426838,"accession":"0001437749-22-021986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-021986","line_url":"/filing/0001437749-22-021986#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164.0,"shares_display":"164","price_per_share":2.5896,"price_display":"2.59","price_state":"stated","total_value":424.6944,"total_display":"424.69","total_whole":"425","shares_owned_after":111413.0,"shares_owned_after_display":"111,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-07","scope":"insider"},{"id":6327354,"accession":"0001437749-22-018993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-018993","line_url":"/filing/0001437749-22-018993#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161.0,"shares_display":"161","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":465.29,"total_display":"465.29","total_whole":"465","shares_owned_after":111577.0,"shares_owned_after_display":"111,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-04","scope":"insider"},{"id":9288292,"accession":"0001437749-22-018991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-018991","line_url":"/filing/0001437749-22-018991#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9328.0,"shares_display":"9,328","price_per_share":2.6315,"price_display":"2.63","price_state":"stated","total_value":24546.632,"total_display":"24,546.63","total_whole":"24,547","shares_owned_after":111738.0,"shares_owned_after_display":"111,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-08-04","scope":"insider"},{"id":6624901,"accession":"0001437749-22-016850","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-016850","line_url":"/filing/0001437749-22-016850#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5835.0,"shares_display":"5,835","price_per_share":2.6315,"price_display":"2.63","price_state":"stated","total_value":15354.8025,"total_display":"15,354.80","total_whole":"15,355","shares_owned_after":64625.0,"shares_owned_after_display":"64,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-07","scope":"insider"},{"id":6601221,"accession":"0001437749-22-014434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-014434","line_url":"/filing/0001437749-22-014434#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162.0,"shares_display":"162","price_per_share":1.9218,"price_display":"1.92","price_state":"stated","total_value":311.3316,"total_display":"311.33","total_whole":"311","shares_owned_after":121066.0,"shares_owned_after_display":"121,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider"},{"id":6449747,"accession":"0001437749-22-010926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-010926","line_url":"/filing/0001437749-22-010926#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":2.3401,"price_display":"2.34","price_state":"stated","total_value":386.1165,"total_display":"386.12","total_whole":"386","shares_owned_after":121228.0,"shares_owned_after_display":"121,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-04","scope":"insider"},{"id":6683813,"accession":"0001437749-22-008328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-008328","line_url":"/filing/0001437749-22-008328#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":206.0,"shares_display":"206","price_per_share":3.078,"price_display":"3.08","price_state":"stated","total_value":634.068,"total_display":"634.07","total_whole":"634","shares_owned_after":121393.0,"shares_owned_after_display":"121,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":6180355,"accession":"0001437749-22-005306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-005306","line_url":"/filing/0001437749-22-005306#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":169.0,"shares_display":"169","price_per_share":2.262,"price_display":"2.26","price_state":"stated","total_value":382.278,"total_display":"382.28","total_whole":"382","shares_owned_after":59423.0,"shares_owned_after_display":"59,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-04","scope":"insider"},{"id":6696472,"accession":"0001437749-22-002412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-002412","line_url":"/filing/0001437749-22-002412#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199.0,"shares_display":"199","price_per_share":2.4822,"price_display":"2.48","price_state":"stated","total_value":493.9578,"total_display":"493.96","total_whole":"494","shares_owned_after":59592.0,"shares_owned_after_display":"59,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider"},{"id":6600986,"accession":"0001437749-22-000444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-000444","line_url":"/filing/0001437749-22-000444#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7484.0,"shares_display":"7,484","price_per_share":3.1896,"price_display":"3.19","price_state":"stated","total_value":23870.9664,"total_display":"23,870.97","total_whole":"23,871","shares_owned_after":59791.0,"shares_owned_after_display":"59,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":4503508,"accession":"0001437749-21-027954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-027954","line_url":"/filing/0001437749-21-027954#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162.0,"shares_display":"162","price_per_share":2.95,"price_display":"2.95","price_state":"stated","total_value":477.9,"total_display":"477.90","total_whole":"478","shares_owned_after":67275.0,"shares_owned_after_display":"67,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":4957178,"accession":"0001209191-21-062788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-062788","line_url":"/filing/0001209191-21-062788#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156.0,"shares_display":"156","price_per_share":5.671,"price_display":"5.67","price_state":"stated","total_value":884.676,"total_display":"884.68","total_whole":"885","shares_owned_after":67437.0,"shares_owned_after_display":"67,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":5271549,"accession":"0001437749-21-023380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-023380","line_url":"/filing/0001437749-21-023380#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161.0,"shares_display":"161","price_per_share":6.2001,"price_display":"6.20","price_state":"stated","total_value":998.2161,"total_display":"998.22","total_whole":"998","shares_owned_after":67593.0,"shares_owned_after_display":"67,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-06","scope":"insider"},{"id":4628673,"accession":"0001209191-21-054896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054896","line_url":"/filing/0001209191-21-054896#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":7.511,"price_display":"7.51","price_state":"stated","total_value":1164.205,"total_display":"1,164.20","total_whole":"1,164","shares_owned_after":67754.0,"shares_owned_after_display":"67,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5429533,"accession":"0001209191-21-049435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-049435","line_url":"/filing/0001209191-21-049435#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154.0,"shares_display":"154","price_per_share":7.5421,"price_display":"7.54","price_state":"stated","total_value":1161.4834,"total_display":"1,161.48","total_whole":"1,161","shares_owned_after":67909.0,"shares_owned_after_display":"67,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":4999630,"accession":"0001209191-21-045599","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-045599","line_url":"/filing/0001209191-21-045599#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":9.2588,"price_display":"9.26","price_state":"stated","total_value":1435.114,"total_display":"1,435.11","total_whole":"1,435","shares_owned_after":68063.0,"shares_owned_after_display":"68,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":4570763,"accession":"0001209191-21-038294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-038294","line_url":"/filing/0001209191-21-038294#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152.0,"shares_display":"152","price_per_share":10.741,"price_display":"10.74","price_state":"stated","total_value":1632.632,"total_display":"1,632.63","total_whole":"1,633","shares_owned_after":68218.0,"shares_owned_after_display":"68,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":4424228,"accession":"0001209191-21-030355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-030355","line_url":"/filing/0001209191-21-030355#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152.0,"shares_display":"152","price_per_share":9.9104,"price_display":"9.91","price_state":"stated","total_value":1506.3808,"total_display":"1,506.38","total_whole":"1,506","shares_owned_after":68370.0,"shares_owned_after_display":"68,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider"},{"id":4179007,"accession":"0001209191-21-025730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-025730","line_url":"/filing/0001209191-21-025730#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":9.8029,"price_display":"9.80","price_state":"stated","total_value":1519.4495,"total_display":"1,519.45","total_whole":"1,519","shares_owned_after":68522.0,"shares_owned_after_display":"68,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider"},{"id":5286760,"accession":"0001209191-21-017852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017852","line_url":"/filing/0001209191-21-017852#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154.0,"shares_display":"154","price_per_share":10.1356,"price_display":"10.14","price_state":"stated","total_value":1560.8824,"total_display":"1,560.88","total_whole":"1,561","shares_owned_after":68677.0,"shares_owned_after_display":"68,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":4087275,"accession":"0001209191-21-007808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-007808","line_url":"/filing/0001209191-21-007808#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":179.0,"shares_display":"179","price_per_share":12.2607,"price_display":"12.26","price_state":"stated","total_value":2194.6653,"total_display":"2,194.67","total_whole":"2,195","shares_owned_after":13236.0,"shares_owned_after_display":"13,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-04","scope":"insider"},{"id":4086873,"accession":"0001209191-21-002341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002341","line_url":"/filing/0001209191-21-002341#line-1","is_derivative":false,"issuer_cik":"0001401667","issuer_name":"PUMA BIOTECHNOLOGY, INC.","issuer_ticker":"PBYI","issuer_name_source":null,"issuer_url":"/issuer/0001401667","owner_cik":"0001758507","owner_name":"NOUGUES MAXIMO F","owner_display_name":"NOUGUES MAXIMO F","owner_url":"/insider/0001758507","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":10.2239,"price_display":"10.22","price_state":"stated","total_value":21930.2655,"total_display":"21,930.27","total_whole":"21,930","shares_owned_after":13415.0,"shares_owned_after_display":"13,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401667","name":"PUMA BIOTECHNOLOGY, INC.","url":"/issuer/0001401667","role":"Officer (Chief Financial Officer)","n_filings":34,"first_seen":"2021-01-06","last_seen":"2026-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001758507","retrieved_at":"2026-08-27T15:57:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}